voltaren emulgel gel 1%
novartis consumer health sa - gel - 1%
voltaren emulgel gel 1%
novartis consumer health sa - gel - 1%
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - virusul gripei de suprafață (hemaglutinină și neuraminidază) de tulpina a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - imunizarea activă împotriva subtipului h5n1 al virusului gripal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
venoruton 300 mg
kemwell ab - suedia - troxerutinum - caps. - 300mg - medicatia capilarelor (capilarotonice) bioflavonoide
orofar 1 mg/1 mg
kemwell ab - suedia - combinatii - compr. de supt - 1mg/1mg - medicamente pentru zona oro-faringiana antiseptice
tavegyl 1 mg
famar italia s.p.a. - elvetia - clemastinum - compr. - 1mg - antihistaminice de uz sistemic aminoalchileteri
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).
tobi 300 mg/5 ml
novartis pharma gmbh - germania - tobramycinum - sol. pt. inhalare prin nebulizator - 300mg/5ml - antibiotice aminoglicozidice alte aminoglicozide
tobi 300 mg/5 ml
novartis pharma gmbh - germania - tobramycinum - sol. de inhalat prin nebulizator - 300mg/5ml - antibiotice aminoglicozidice alte aminoglicozide
sandostatin solutie injectabila 0,05 mg/ml
novartis pharma ag - octreotidum - solutie injectabila - 0,05 mg/ml